ValuationViz

AXSM fund manager activity

Axsome Therapeutics, Inc · Nasdaq. Reported by 4 tracked fund managers in their 13F filings, Q2 2019 to Q2 2026.

Q4 2025

ManagerActivitySharesValue% of portfolioFiled
Torray FundsTrimmed14,794$2,701,9760.39%Jan 28, 2026

Q3 2025

ManagerActivitySharesValue% of portfolioFiled
Polen Capital ManagementSold out——0.00%Nov 12, 2025
Torray FundsAdded17,419$2,115,5380.29%Oct 22, 2025

Newer quarters · Older quarters